Curanex Pharmaceuticals Inc’s Quiet Period To End on October 6th (NASDAQ:CURX)

Curanex Pharmaceuticals’ (NASDAQ:CURX) quiet period will end on Monday, October 6th. Curanex Pharmaceuticals had issued 3,750,000 shares in its initial public offering on August 26th. The total size of the offering was $15,000,000 based on an initial share price of $4.00. During Curanex Pharmaceuticals’ quiet period, insiders and underwriters involved in the IPO are restricted from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen upgraded Curanex Pharmaceuticals to a “hold” rating in a research note on Saturday, August 30th.

Curanex Pharmaceuticals Stock Performance

Shares of CURX stock opened at $0.79 on Monday. Curanex Pharmaceuticals has a 1-year low of $0.66 and a 1-year high of $9.18.

About Curanex Pharmaceuticals

Curanex is a developmental stage pharmaceutical company dedicated to discovering, developing and commercializing innovative botanical drugs to treat patients suffering from inflammatory diseases. Our mission is to address significant unmet medical needs and improve patients’ lives by harnessing the power of natural substances.